REPLICEL LIFE SCIENCES INC. Equity
REPLICEL LIFE SCIENCES INC. had Equity of -CAD 5.92 million as of 2022-12-31, per its 20-F filed 2023-05-02.
Discontinued › Notes
ifrs-full:Equity · last filed 2023-05-02
- 2022-12-31: Equity -5.92M CAD.
- 2021-12-31: Equity -6.84M CAD.
- 2021-12-30: Equity -6.84M CAD.
- 2020-12-31: Equity -5.06M CAD.
| Period end | Equity | Equity as first filed |
|---|---|---|
| 2022-12-31 | -5.92M CAD 20-F · filed 2023-05-02 | |
| 2021-12-31 | -6.84M CAD 20-F · filed 2023-05-02 | |
| 2021-12-30 | -6.84M CAD 20-F · filed 2023-05-02 | |
| 2020-12-31 | -5.06M CAD 20-F · filed 2023-05-02 | |
| 2019-12-31 | -4.43M CAD 20-F · filed 2023-05-02 | -2.93M CAD 20-F · filed 2020-08-05 |
| 2019-06-30 | -3.41M CAD 20-F/A · filed 2021-03-31 | |
| 2019-03-31 | -2.47M CAD 20-F/A · filed 2021-03-31 | |
| 2018-12-31 | -1.90M CAD 20-F/A · filed 2022-09-13 | -455.18K CAD 20-F · filed 2019-04-30 |
| 2017-12-31 | -320.00K CAD 20-F · filed 2021-05-17 | |
| 2016-12-31 | 1.21M CAD 20-F/A · filed 2021-03-31 | |
| 2015-12-31 | -601.78K CAD 20-F · filed 2019-04-30 | |
| 2014-12-31 | 1.81M CAD 20-F · filed 2018-05-11 |